ASX:VITPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Vitura Health Ltd
$0.031
+$0.001 (+1.67%)
Day Range
$0.030 – $0.031
52 Week Range
$0.028 – $0.075
Volume
47.95K
Avg Volume (10D)
307.18K
Market Cap
$20.21M
P/E Ratio
5.14
Price Chart
Market Statistics
Open$0.030
Previous Close$0.030
Day High$0.031
Day Low$0.030
52 Week High$0.075
52 Week Low$0.028
Valuation
Market Cap20.21M
Shares Outstanding662.74M
P/E Ratio (Annual)5.14
P/E Ratio (TTM)23.53
Dividend Yield7.14%
Price to Book0.40
Trading Activity
Volume47.95K
Value Traded1.44K
Bid$0.030 × 109,499
Ask$0.031 × 60,873
Performance
1 Day-5.08%
5 Day-12.50%
13 Week-31.71%
52 Week-57.58%
YTD-54.10%
Technical Indicators
RSI (14)42.66
50-Day SMA$0.035
200-Day SMA$0.053
Latest News
Biotechnology
Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million
VIT hits profitability: Doctors on Demand tops 1 million consultations since FY2024; revenue rises 54% to FY2026 Q1-Q3, EBITDA positive at 5%.
Industrials & Juniors
Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products
Vitura Health strikes MedReleaf distribution deal, targeting up to $15m extra annual revenue via Canview across 4,700 pharmacies.
Hot Topics
Trump’s CBD Comments Ignite US Cannabis Stocks Surge – Will ASX Companies Follow Suit?
Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare, “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs. He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could […]